In gastric stomach cancer (AGS) cells, L-OHP can also act on tumor associated NADH oxidase, reduce the NAD+/NADH ratio, and reduce the activity of NAD+-dependent SIRT1, thereby enhancing the acetylation of p53 and apoptosis (Chen et al., 2017). Here, TP53 is linked to neoplasm.